Atria Wealth Solutions’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.4M Sell
45,077
-33,104
-42% -$2.63M 0.1% 233
2025
Q1
$5.69M Buy
78,181
+11,502
+17% +$906K 0.07% 299
2024
Q4
$4.83M Buy
66,679
+48,249
+262% +$3.66M 0.05% 361
2024
Q3
$1.5M Sell
18,430
-62,560
-77% -$5.44M 0.02% 752
2024
Q2
$8.63M Sell
80,990
-5,500
-6% -$527K 0.1% 218
2024
Q1
$8.42M Buy
86,490
+1,660
+2% +$146K 0.09% 226
2023
Q4
$6.66M Sell
84,830
-1,070
-1% -$72.9K 0.08% 242
2023
Q3
$5.4M Buy
85,900
+510
+0.6% +$33.5K 0.08% 270
2023
Q2
$5.5M Buy
85,390
+2,120
+3% +$119K 0.08% 261
2023
Q1
$4.43M Buy
83,270
+1,800
+2% +$88.3K 0.07% 293
2022
Q4
$3.44M Sell
81,470
-6,050
-7% -$253K 0.06% 345
2022
Q3
$3.21M Sell
87,520
-1,800
-2% -$80.1K 0.06% 331
2022
Q2
$3.81M Sell
89,320
-15,910
-15% -$757K 0.07% 283
2022
Q1
$5.66M Buy
+105,230
New +$6.13M 0.09% 231

Other funds holding LRCX

Atria Wealth Solutions's LRCX Position: Q2 2025 in Review

Atria Wealth Solutions reduced its Lam Research (LRCX) stake by 42% in Q2 2025, selling an estimated $2.63M and leaving 45,077 shares worth $4.4M. The position accounts for 0.1% of the portfolio, ranked #233.

Atria Wealth Solutions first reported a position in LRCX in Q1 2022 and has held it in 14 quarters since. The position peaked at $8.63M in Q2 2024. 1,883 funds tracked by Wall St. Rank hold LRCX as of Q2 2025.

  • Atria Wealth Solutions held 45,077 shares of Lam Research worth $4.4M as of Q2 2025.
  • Atria Wealth Solutions sold 33,104 Lam Research shares in Q2 2025, an estimated $2.63M.
  • Lam Research made up 0.1% of Atria Wealth Solutions's portfolio in Q2 2025, its #233 holding.
  • Atria Wealth Solutions first reported a position in Lam Research in Q1 2022 and has held it in 14 quarters since.
  • Atria Wealth Solutions's Lam Research position peaked at $8.63M in Q2 2024.
  • 1,883 funds tracked by Wall St. Rank held Lam Research as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.